| | LOC130059466, LOC130059467 +1738 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC130059153, LOC130059154 +1426 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC400553, LOC654780 +832 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LINC01081, LINC01082 +781 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LINC00917, LINC01081 +566 more | Copy number gain | See cases | |
| | LOC130059799, LOC130059800 +531 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | LOC130059839, LOC130059840 +18 more | Deletion | Fanconi anemia | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Deletion | not provided | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | not provided +1 more | |
| | | Single nucleotide variant | not provided +1 more | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant | not provided | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | not provided +1 more | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (genic downstream transcript variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Deletion (5 prime UTR variant) | Malignant Melanoma Susceptibility | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Duplication (5 prime UTR variant) | Malignant Melanoma Susceptibility | |
| | | Deletion (inframe_deletion +1 more) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (5 prime UTR variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 +1 more | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (nonsense) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Microsatellite (inframe_deletion) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Deletion (frameshift variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (synonymous variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |
| | | Single nucleotide variant (missense variant) | Melanoma, cutaneous malignant, susceptibility to, 5 | |